Siamab Therapeutics' Grant - III Round

Siamab Therapeutics raised a round of funding on May 06, 2010. Investors include Qualifying Therapeutic Discovery Project.

Siamab Therapeutics, formerly Sialix, is a biopharmaceutical company developing novel cancer immunotherapies. Siamab has developed a platform of technologies that enable the rapid discovery and develo…

Articles about Siamab Therapeutics' Grant - III Round: